Comment on “Comparison of secondary neutron dose in proton therapy resulting from the use of a tungsten alloy MLC or a brass collimator system” [Med. Phys. 38(11), 6248-6256 (2011)]-Reference-Cited by-同舟云学术

Comment on “Comparison of secondary neutron dose in proton therapy resulting from the use of a tungsten alloy MLC or a brass collimator system” [Med. Phys. 38(11), 6248-6256 (2011)]

Published:2012-04-03 Issue:4 Volume:39 Page:2303-2305
ISSN:0094-2405
Container-title:Medical Physics
language:en
Short-container-title:Med. Phys.

Author:

Moskvin Vadim,Cheng Chee-Wai,Zhao Qingya,Das Indra J.

Publisher

Wiley

Subject

General Medicine

Reference13 articles.

1. Comparison of secondary neutron dose in proton therapy resulting from the use of a tungsten alloy MLC or a brass collimator system;Diffenderfer;Med. Phys.,2011

2. Pitfalls of tungsten multileaf collimator in proton beam therapy;Moskvin;Med. Phys.,2011

3. A. Ferrari P. R. Sala A. Fasso J. Ranft FLUKA : A multi-particle transport code 2005

4. GEANT4-A simulation toolkit;Agostinelli;Nucl. Instrum. Methods A,2003

5. An integral test of FLUKA nuclear models with 160 MeV proton beams in multi-layer Faraday cups;Rinaldi;Phys. Med. Biol.,2011

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Collimator design for spatially-fractionated proton beams for radiobiology research;Physics in Medicine and Biology;2016-06-30

2. Optimization of GATE and PHITS Monte Carlo code parameters for uniform scanning proton beam based on simulation with FLUKA general-purpose code;Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms;2014-10

3. The disadvantages of a multileaf collimator for proton radiotherapy outweigh its advantages;Medical Physics;2014-01-06

4. Distributions of secondary particles in proton and carbon-ion therapy: a comparison between GATE/Geant4 and FLUKA Monte Carlo codes;Physics in Medicine and Biology;2013-04-10

5. Reply to “Comment on ‘Comparison of secondary neutron dose in proton therapy resulting from the use of a tungsten alloy MLC or a brass collimator system’” [Med. Phys. 38(11), 6248-6256 (2011)];Medical Physics;2012-04-03